Home › Glioblastoma › Arizona
Glioblastoma clinical trials in Arizona
13 studies for Glioblastoma are looking for participants at sites in Arizona.
Cities in Arizona
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- Mayo Clinic Hospital in Arizona, Phoenix
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05432804Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- Mayo Clinic Arizona, Phoenix
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05902169Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- HonorHealth Scottsdale Osborn Medical Center, Scottsdale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07195591Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Banner MD Anderson Cancer Center, Gilbert
- Arizona Cancer Center at UMC North/University Medical Center, Tucson
RecruitingPhase 1/2
Ages 18 to 99 · All sexes · Updated Sep 22, 2026 · NCT06814496SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Mayo Clinic - Arizona, Phoenix
- St. Joseph's Hospital and Medical Center, Phoenix
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05303519BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors
- St. Joseph's Hospital and Medical Center, Phoenix
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07485049Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
- Mayo Clinic in Arizona, Phoenix
Recruiting
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07091864Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
- Honor Health, Scottsdale
Recruiting
Ages 18 to 85 · All sexes · Updated Jul 21, 2026 · NCT06910306A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
- Mayo Clinic Hospital, Phoenix
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT07185880Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Mayo Clinic Scottsdale, Scottsdale
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT06810544A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases
- St. Joseph's Hospital and Medical Center, Phoenix
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Mar 6, 2026 · NCT07268053A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
- Chandler Regional Medical Center, Chandler
- St. Joseph's Hospital and Medical Center, Phoenix
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Nov 20, 2025 · NCT06072586SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.